<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03428945</url>
  </required_header>
  <id_info>
    <org_study_id>Hydroxychloroquine</org_study_id>
    <secondary_id>UC4DK117009</secondary_id>
    <secondary_id>UC4DK106993</secondary_id>
    <nct_id>NCT03428945</nct_id>
  </id_info>
  <brief_title>Hydroxychloroquine in Individuals At-risk for Type 1 Diabetes Mellitus</brief_title>
  <acronym>TN-22</acronym>
  <official_title>Hydroxychloroquine for Prevention of Abnormal Glucose Tolerance and Diabetes in Individuals At-risk for Type 1 Diabetes Mellitus (T1D)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Juvenile Diabetes Research Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is a 2-arm, double blinded, multicenter, 2:1 randomized, placebo controlled
      clinical trial. Subjects will receive hydroxychloroquine or placebo and close monitoring for
      progression of T1D.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is testing a medication, called hydroxychloroquine (HCQ) to assess safety and
      effectiveness to prevent individuals at risk of type 1 diabetes (T1D) from progressing to
      type 1 diabetes.

      HCQ is approved by the U.S. Food and Drug Administration as a treatment for malaria, lupus,
      and rheumatoid arthritis. HCQ has been used extensively for treatment of autoimmune disease
      in adults, children, and during pregnancy. This medication has not previously been studied as
      a treatment to prevent T1D.

      The goal of this study is to learn if HCQ can help prevent or delay progression from normal
      glucose tolerance (Stage 1) to abnormal glucose tolerance (Stage 2) or type 1 diabetes (Stage
      3).

      The study involves 5 visits in the first 6 months, then 1 visit every 6 months for the
      remainder of the study.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 15, 2018</start_date>
  <completion_date type="Anticipated">August 2024</completion_date>
  <primary_completion_date type="Anticipated">August 2024</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Treatment assignment (active drug: placebo) will be assigned in a parallel, randomized, 2:1 model. Assignment will be stratified based on prior treatment for T1D prevention and age.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>Active drug and placebo will be identical in appearance and packaging</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change from Treatment Assignment Glucose Tolerance to Abnormal Glucose Tolerance or Diabetes</measure>
    <time_frame>Glucose tolerance is measured every 6 months for approximately 6 years</time_frame>
    <description>The primary outcome is the time from treatment assignment to changes in glucose tolerance. The time to development of abnormal glucose tolerance or the diagnosis of type 1 diabetes will be measured to identify these changes.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">201</enrollment>
  <condition>Type1 Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Hydroxychloroquine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hydroxychloroquine compound for oral use</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo tablet matching active drug</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydroxychloroquine</intervention_name>
    <description>Hydroxychloroquine for oral administration, dosed by weight</description>
    <arm_group_label>Hydroxychloroquine</arm_group_label>
    <other_name>Plaquenil</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo tablet identical to active drug</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Inactive Drug</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Participant in TrialNet Pathway to Prevention Study (TN01)

          2. Age 3 years or greater at the time of randomization

          3. Willing to provide informed consent

          4. Normal glucose tolerance by OGTT within 7 weeks (no more than 52 days) of baseline

          5. Two or more diabetes-related autoantibodies present on two separate samples

          6. Weight of 12 kg or greater at screening

          7. If a female participant with reproductive potential, willing to avoid pregnancy and
             undergo pregnancy testing prior to randomization and at each study visit

          8. Anticipated ability to swallow study medication.

        Exclusion Criteria:

          1. Abnormal Glucose Tolerance or Diabetes

          2. History of treatment with insulin or other diabetes therapies

          3. Ongoing use of medications known to influence glucose tolerance

          4. Ongoing or anticipated future use of medications known to have untoward interactions
             with hydroxychloroquine

          5. Known hypersensitivity to 4-aminoquinoline compounds

          6. G6PD deficiency

          7. History of retinopathy

          8. Have an active infection at time of randomization

          9. Have serologic evidence of current or past HIV, Hepatitis B (positive for Hepatitis B
             core antibody or surface antigen), or Hepatitis C infection

         10. Deemed unlikely or unable to comply with the protocol or have any complicating medical
             issues, including prolonged QT interval, a disease previously or likely in the future
             to require immunosuppression, or abnormal clinical laboratory results that interfere
             with study conduct or cause increased risk.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carla Greenbaum, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Type 1 Diabetes TrialNet</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lisa Rafkin</last_name>
    <phone>305-243-6146</phone>
    <email>lrafkin@miami.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ryan O'Donnell</last_name>
    <phone>813-396-9551</phone>
    <email>Ryan.O'Donnell@epi.usf.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Children's Hospital Los Angeles</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90027</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Bisno</last_name>
      <phone>323-361-8641</phone>
      <email>dbisno@chla.usc.edu</email>
    </contact>
    <investigator>
      <last_name>Roshanak Monzavi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California - San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebecca Wesch</last_name>
      <phone>415-476-5984</phone>
      <email>rebecca.wesch@ucsf.edu</email>
    </contact>
    <contact_backup>
      <last_name>Karen Ko</last_name>
      <phone>415-514-3730</phone>
      <email>karen.ko@ucsf.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Stephen Gitelman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Trudy Esrey</last_name>
      <phone>650-498-4450</phone>
      <email>tesrey@stanford.edu</email>
    </contact>
    <investigator>
      <last_name>Darrell Wilson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Barbara Davis Center</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Betsy Burke</last_name>
      <phone>303-724-6766</phone>
      <email>Betsy.Burke@ucdenver.edu</email>
    </contact>
    <investigator>
      <last_name>Andrea Steck, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Yale University School of Medicine</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06519</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurie Feldman</last_name>
      <phone>203-737-2760</phone>
      <email>laurie.feldman@yale.edu</email>
    </contact>
    <investigator>
      <last_name>Kevan Herold, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Hosford</last_name>
      <phone>352-294-5759</phone>
      <email>jennifer.hosford@medicine.ufl.edu</email>
    </contact>
    <contact_backup>
      <last_name>Paula Towe</last_name>
      <phone>352-294-5761</phone>
      <email>pdtowe@peds.ufl.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Desmond Schatz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Della Matheson</last_name>
      <phone>305-243-3781</phone>
      <email>dmatheso@med.miami.edu</email>
    </contact>
    <contact_backup>
      <last_name>Natalia Sanders-Branca</last_name>
      <phone>305-243-6616</phone>
      <email>n.sanders1@med.miami.edu</email>
    </contact_backup>
    <investigator>
      <last_name>David Baidal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>USF Diabetes Center</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emily Eyth</last_name>
      <phone>813-974-9817</phone>
      <email>emilyeyth@health.usf.edu</email>
    </contact>
    <investigator>
      <last_name>Henry Rodriguez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory Children's Center</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Margaret Jenkins</last_name>
      <phone>404-712-0051</phone>
      <email>mjenk03@emory.edu</email>
    </contact>
    <investigator>
      <last_name>Andrew Muir, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Luke's Humphreys Diabetes Center</name>
      <address>
        <city>Boise</city>
        <state>Idaho</state>
        <zip>83702</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurie Cartwright</last_name>
      <phone>208-381-8177</phone>
      <email>cartwril@slhs.org</email>
    </contact>
    <investigator>
      <last_name>Daniel Flynn, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rocky Mountain Clinical Research</name>
      <address>
        <city>Idaho Falls</city>
        <state>Idaho</state>
        <zip>83404</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kimberly Barbieri</last_name>
      <phone>208-528-9643</phone>
      <email>kimberly.barbieri@idahomed.com</email>
    </contact>
    <investigator>
      <last_name>David Liljenquist</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gail Gannon</last_name>
      <phone>773-702-3853</phone>
      <email>ggannon@uchicago.edu</email>
    </contact>
    <investigator>
      <last_name>Louis Philipson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Indiana University - Riley Hospital for Children</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Spall</last_name>
      <phone>317-278-8879</phone>
      <email>malnicho@iu.edu</email>
    </contact>
    <investigator>
      <last_name>Linda DiMeglio, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Iowa</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joanne Cabbage</last_name>
      <phone>319-335-7434</phone>
      <email>joanne-cabbage@uiowa.edu</email>
    </contact>
    <investigator>
      <last_name>Michael Tansey, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Kentucky/UK Healthcare</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40504</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathy Edwards</last_name>
      <phone>859-218-6717</phone>
      <email>kathy.edwards@uky.edu</email>
    </contact>
    <investigator>
      <last_name>Kathryn Thrailkill, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Louisville Pediatric Endocrinology</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephany Eubanks</last_name>
      <phone>502-588-0491</phone>
      <email>slhine01@exchange.louisville.edu</email>
    </contact>
    <investigator>
      <last_name>Kupper Wintergerst, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Joslin Diabetes Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nora Bryant</last_name>
      <phone>617-309-4141</phone>
      <email>nora.bryant@joslin.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Jason Gaglia, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Michigan Health System</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrea Haddad</last_name>
      <phone>734-615-4079</phone>
      <email>ashaddad@med.umich.edu</email>
    </contact>
    <investigator>
      <last_name>Inas Thomas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Minnesota</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Darcy Weingartner</last_name>
      <phone>612-624-5958</phone>
      <email>darcy@umn.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jessica Ruedy</last_name>
      <phone>612-624-6617</phone>
      <email>sweet093@umn.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Toni Moran, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Children's Mercy Hospital</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64108</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lacey Deardoff</last_name>
      <phone>816-960-8943</phone>
      <email>lrdeardoff@cmh.edu</email>
    </contact>
    <investigator>
      <last_name>Wayne Moore, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Palm Research Center, Inc.</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89148</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Natasha Sushenko</last_name>
      <phone>702-736-5161</phone>
      <email>natasha@palmresearchcenter.com</email>
    </contact>
    <investigator>
      <last_name>Samer Nakhle, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UBMD Pediatrics</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amanda House</last_name>
      <phone>716-323-0075</phone>
      <email>ahouse@upa.chob.edu</email>
    </contact>
    <investigator>
      <last_name>Teresa Quattrin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Columbia University</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Pollak</last_name>
      <phone>212-851-5465</phone>
      <email>sjp2174@columbia.edu</email>
    </contact>
    <contact_backup>
      <last_name>Analia Alvarez</last_name>
      <phone>212-851-5465</phone>
      <email>aa516@cumc.columbia.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Robin Goland, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Joslin Center at SUNY Upstate Medical University</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lynn Agostini</last_name>
      <phone>315-464-9012</phone>
      <email>agostinl@upstate.edu</email>
    </contact>
    <investigator>
      <last_name>Ramachandra Naik, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heather Wojanowski</last_name>
      <phone>216-445-2282</phone>
      <email>WOJANOH@ccf.org</email>
    </contact>
    <investigator>
      <last_name>Sumana Narasimhan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The University of Oklahoma</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linda Weber</last_name>
      <phone>405-271-8001</phone>
      <phone_ext>43074</phone_ext>
      <email>linda-weber@ouhsc.edu</email>
    </contact>
    <investigator>
      <last_name>David Sparling, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Childrens Hospital of Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104-4399</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beth Schwartzman</last_name>
      <phone>267-426-5718</phone>
      <email>schwartzmann@email.chop.edu</email>
    </contact>
    <investigator>
      <last_name>Lorraine Levitt Katz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Groscost</last_name>
      <phone>412-692-7241</phone>
      <email>david.groscost@chp.edu</email>
    </contact>
    <contact_backup>
      <last_name>Kelli Delallo</last_name>
      <phone>412-692-5210</phone>
      <email>kelli.delallo@chp.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Dorothy Becker, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Endocrinology Specialist / Greenville Health System</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29605</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shirley Parker</last_name>
      <phone>864-455-3261</phone>
      <email>Shirley.Parker@prismahealth.org</email>
    </contact>
    <investigator>
      <last_name>Sandra Weber, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>GHS - Pediatric Endocrinology</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29615</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Looper</last_name>
      <phone>864-454-5168</phone>
      <email>llooper@ghs.org</email>
    </contact>
    <investigator>
      <last_name>Elaine Apperson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vanderbilt Eskind Diabetes Clinic</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brenna Dixon</last_name>
      <phone>615-337-9597</phone>
      <email>brenna.dixon@vanderbilt.edu</email>
    </contact>
    <contact_backup>
      <last_name>Faith Brendle</last_name>
      <phone>615-936-8638</phone>
      <email>faith.brendle@vanderbilt.edu</email>
    </contact_backup>
    <investigator>
      <last_name>William Russell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lauren Boyles</last_name>
      <phone>241-648-4717</phone>
      <email>lauren.boyles@utsouthwestern.edu</email>
    </contact>
    <investigator>
      <last_name>Philip Raskin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hillarie Slater</last_name>
      <phone>801-585-6227</phone>
      <email>hillarie.slater@hsc.utah.edu</email>
    </contact>
    <investigator>
      <last_name>Carol Foster, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Virginia Health System</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jordan McCoy, BS</last_name>
      <phone>434-297-5132</phone>
      <email>JO4U@hscmail.mcc.virginia.edu</email>
    </contact>
    <investigator>
      <last_name>Christina Solorzano, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Benaroya Research Institute</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Ramey</last_name>
      <phone>206-342-6945</phone>
      <email>mramey@benaroyaresearch.org</email>
    </contact>
    <contact_backup>
      <last_name>Marli McCulloch-Olson</last_name>
      <phone>206-515-5239</phone>
      <email>Marli@benaroyaresearch.org</email>
    </contact_backup>
    <investigator>
      <last_name>Carla Greenbaum, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical College of Wisconsin</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clare Bingham-Tyson</last_name>
      <email>cbinghamtyson@mcw.edu</email>
    </contact>
    <contact_backup>
      <last_name>Joanna Kramer</last_name>
      <email>jkramer@mcw.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Susanne Cabrera, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rosanna Fiallo-Scharer, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Women's and Children's Hospital, Adelaide</name>
      <address>
        <city>North Adelaide</city>
        <state>South Australia</state>
        <zip>5006</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kirsty Herewane</last_name>
      <phone>0881617349</phone>
      <email>kirsty.herewane@sa.gov.au</email>
    </contact>
    <investigator>
      <last_name>Jennifer Couper, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Walter and Eliza Hall Institute of Medical Research</name>
      <address>
        <city>Parkville</city>
        <state>Victoria</state>
        <zip>3052</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leanne Redl</last_name>
      <phone>61 3 9342 7063</phone>
      <email>leanne.redl@mh.org.au</email>
    </contact>
    <investigator>
      <last_name>Peter Colman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>John Wentworth, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Eastern Ontario</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1H8L1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine Watson</last_name>
      <phone>6137377600</phone>
      <phone_ext>3600</phone_ext>
      <email>cwatson@cheo.on.ca</email>
    </contact>
    <investigator>
      <last_name>Margaret Lawson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Hospital For Sick Kids</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G-1X8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary-Jo Ricci</last_name>
      <phone>416-813-7654</phone>
      <phone_ext>202634</phone_ext>
      <email>maryjo.ricci@sickkids.ca</email>
    </contact>
    <investigator>
      <last_name>Diane Wherrett, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IWK Health Center</name>
      <address>
        <city>Halifax</city>
        <zip>NS B3K 6R8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maggie Flemming</last_name>
      <email>maggie.flemming@iwk.nshealth.ca</email>
    </contact>
    <investigator>
      <last_name>Elizabeth Cummings, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Arati Mokashi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>San Raffaele Hospital</name>
      <address>
        <city>Milan</city>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pauline Grogan</last_name>
      <phone>39-02-2643-3176</phone>
      <email>grogan.pauline@hsr.it</email>
    </contact>
    <investigator>
      <last_name>Emanuele Bosi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Skane University Hospital</name>
      <address>
        <city>Malmö</city>
        <zip>20502</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linda Ahlkvist</last_name>
      <phone>+46 40 391915</phone>
      <email>linda.ahlkvist@med.lu.se</email>
    </contact>
    <investigator>
      <last_name>Henrik Borg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Devon and Exeter Hospital</name>
      <address>
        <city>Exeter</city>
        <state>Devon</state>
        <zip>EX2 5DW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emma Chamberlain</last_name>
      <phone>01392 406437</phone>
      <email>e.chamberlain1@nhs.net</email>
    </contact>
    <contact_backup>
      <last_name>Caroline Harrill</last_name>
      <phone>01392404522</phone>
      <email>caroline.harrill@nhs.net</email>
    </contact_backup>
    <investigator>
      <last_name>Christopher Moudiotis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Plymouth Diabetes Clinical Research Unit</name>
      <address>
        <city>Plymouth</city>
        <state>Devon</state>
        <zip>PLG8BX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emma Storr</last_name>
      <email>emmastorr@nhs.net</email>
    </contact>
    <contact_backup>
      <last_name>Natalie Bond</last_name>
      <email>natalie.bond@nhs.net</email>
    </contact_backup>
    <investigator>
      <last_name>Georgina Selby, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Harrogate and District NHS Foundation Trust</name>
      <address>
        <city>Harrogate</city>
        <state>North Yorkshire</state>
        <zip>HG2 7SX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christine Morgan</last_name>
      <email>c.morgan10@nhs.net</email>
    </contact>
    <investigator>
      <last_name>Peter Hammond, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Bristol</name>
      <address>
        <city>Bristol</city>
        <state>UK</state>
        <zip>BS10 5NB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beth Thorne</last_name>
      <phone>0117 4147917</phone>
      <email>beth.thorne@bristol.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Polly Bingley, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nottingham University Hospitals</name>
      <address>
        <city>Nottingham</city>
        <zip>NG7 2UH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Coupe</last_name>
      <email>anna.coupe@nuh.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Louise Denvir, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Canada</country>
    <country>Italy</country>
    <country>Sweden</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.trialnet.org/</url>
    <description>TrialNet Public Website</description>
  </link>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>January 24, 2018</study_first_submitted>
  <study_first_submitted_qc>February 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 12, 2018</study_first_posted>
  <last_update_submitted>July 8, 2020</last_update_submitted>
  <last_update_submitted_qc>July 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>TrialNet</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydroxychloroquine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

